Mesalamine is a medicine used to treat inflammation in the digestive tract, like in Crohn's disease or ulcerative colitis. It helps reduce swelling and irritation in the bowel. It's often taken as a pill or a liquid. Your doctor will tell you the right dose and how long to take it.
Every report comes from a Lived member, sent anonymously.
Have you tried Mesalamine for Ulcerative Colitis?
Mesalamine is a prescription anti-inflammatory medicine used mainly for mild to moderate ulcerative colitis, a long-term inflammatory bowel disease (IBD) that inflames the lining of the colon and rectum. It is used both to calm a flare (bringing on remission, a period with few or no symptoms) and, for many people, to keep the disease quiet afterward. It belongs to a group called aminosalicylates, also known as 5-aminosalicylic acid (5-ASA) medicines, and is chemically related to aspirin. It is the active part of an older drug, sulfasalazine, without the sulfa component. Mesalamine comes in several forms, and the choice depends largely on how much of the colon is inflamed. Oral brands include Lialda (once-daily delayed-release tablets, approved for adults and for children weighing at least 24 kg, about 53 pounds), Pentasa (capsules for active disease in adults) and Apriso (once-daily capsules for keeping adults in remission). When inflammation is limited to the rectum or the lower colon, treatment can go directly where it is needed: Canasa suppositories treat ulcerative proctitis (inflammation of the rectum only), and Rowasa enemas treat inflammation extending into the lower colon. Asacol and Delzicol are former US brand names; generic versions of many forms are available. Mesalamine is not approved by the US Food and Drug Administration (FDA) for Crohn's disease, the other main type of IBD. Research has not shown that it keeps Crohn's disease in remission better than a placebo, so it is not usually relied on for that condition.
In ulcerative colitis, the immune system drives ongoing inflammation in the inner lining of the colon, which causes diarrhea, bleeding, urgency and cramping. Mesalamine acts mostly on the surface of that lining rather than throughout the body. It appears to reduce the production of inflammatory chemical messengers, such as prostaglandins, in the colon wall, although its exact mechanism is not fully understood. Because the drug works locally, how it gets to the colon matters. Oral products use special coatings or slow-release designs so that most of the dose passes through the stomach and is released farther along the intestine, with only a minority absorbed into the bloodstream. Suppositories and enemas deliver mesalamine directly to the rectum and lower colon, which is why they work well when inflammation is confined to that area but cannot reach disease higher up.
Doses and schedules differ by product, so the instructions for one brand do not carry over to another. Lialda tablets are taken once a day with food. Apriso capsules are taken once a day in the morning, with or without food, and should not be taken together with antacids. Pentasa capsules are usually taken four times a day for active disease. Delayed-release and extended-release tablets and capsules are swallowed whole, not crushed, split or chewed, because breaking them can release the drug too early. Pentasa is the exception: its capsules can be opened and the contents sprinkled on applesauce or yogurt and eaten right away. Canasa suppositories are used once daily at bedtime and work best when kept in for one to three hours or longer. Rowasa enemas are given at bedtime and ideally held overnight, for roughly eight hours. Rectal courses typically last three to six weeks, depending on how symptoms and the bowel lining respond. Suppositories can stain fabrics and other surfaces, so keep them away from bedding and furniture. Drinking enough fluids during treatment helps lower the small risk of kidney stones. Before starting and periodically afterward, a blood test checks how well the kidneys are working.
Most people tolerate mesalamine well. The most commonly reported side effects in adults are headache, gas, abdominal pain, diarrhea and mildly abnormal liver blood tests. Some people become more sensitive to sunlight, especially those with eczema, so sun protection is sensible. A small number of people develop an intolerance reaction that looks like a colitis flare: cramping, abdominal pain and bloody diarrhea, sometimes with fever, headache or rash, that begin or get worse after starting mesalamine. Because this can be mistaken for the disease itself, contact the prescriber promptly if symptoms worsen on treatment; they may tell you to stop the medicine. Rare allergic-type reactions can affect the skin or internal organs, including inflammation of the heart muscle or the sac around the heart. A blistering, peeling or widespread rash, rash with fever, chest pain or shortness of breath means stopping mesalamine and getting medical evaluation right away. Severe pain in the side or back, or blood in the urine, can signal a kidney stone and should be reported to the care team.
People who are allergic to aspirin or other salicylates, or to aminosalicylates such as sulfasalazine, should not take mesalamine. Rowasa enemas also contain a sulfite preservative, so people with a sulfite allergy, which is more common in some people with asthma, should not use them. Some people who reacted badly to sulfasalazine also react to mesalamine, so mention any previous reaction. The kidneys are the main safety concern. Mesalamine can rarely cause kidney inflammation or loss of kidney function, which is why kidney blood tests are part of routine follow-up. The risk needs more careful weighing in people with existing kidney disease and in those taking other medicines that can strain the kidneys, including regular use of nonsteroidal anti-inflammatory drug (NSAID) pain relievers such as ibuprofen or naproxen. People with known liver disease should also discuss the risks, since rare cases of liver failure have been reported in that group. Taking mesalamine with azathioprine or 6-mercaptopurine (immune-suppressing medicines also used for IBD) can increase the risk of low blood counts, so regular complete blood counts are needed with that combination. Older adults may also have a higher risk of blood count changes. For people who are pregnant or planning pregnancy, studies have not reliably linked mesalamine to birth defects or miscarriage, while active ulcerative colitis itself is associated with preterm birth and low birth weight. That balance is worth discussing with the care team rather than stopping on your own. Small amounts pass into breast milk, and a breastfed baby who develops diarrhea should be checked.
Treatment for a flare is judged over weeks rather than days. Not everyone responds. In clinical trials, about 29% of people taking oral mesalamine reached remission during the study period, compared with 17% taking a placebo, so many people did not reach remission in that time. If symptoms do not improve enough, a clinician may raise the dose, add a rectal form to an oral one, or move to stronger treatment such as a corticosteroid or an advanced therapy (a biologic or other targeted medicine that acts on the immune system). Once the disease is in remission, mesalamine is often continued long term because it lowers the chance of relapse. In studies lasting six to twelve months, about 37% of people taking it relapsed compared with 55% taking a placebo. Missing doses is a common reason for relapse, so a schedule that fits daily life, such as once-daily dosing, can matter as much as the brand. Ongoing care usually includes periodic kidney blood tests and regular review of symptoms.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Mesalamine, what you've noticed, or ask the community a question.